3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Recruiting
1
Active not recruiting
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Breast
1
Conditions
Breast Neoplasms
58
Ovarian Neoplasms
7
Neoplasm Metastasis
7
Endometrial Neoplasms
5
Carcinoma, Non-Small-Cell Lung
5
Neoplasms
4
Hereditary Sensory and Autonomic Neuropathies
4
Advanced Breast Cancer
4
Uterine Cervical Neoplasms
3
Triple Negative Breast Neoplasms
3
Squamous Cell Carcinoma of Head and Neck
3
Colorectal Neoplasms
3
Neoplasms by Site
2
Head and Neck Neoplasms
2
Fallopian Tube Neoplasms
2
Carcinoma, Ovarian Epithelial
2
Breast Diseases
2
Advanced Solid Tumors
2
Advanced Solid Tumor
2
Unilateral Breast Neoplasms
1
Spinocerebellar Degenerations
1
Salivary Gland Neoplasms
1
Recurrence
1
Prostatic Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Locoregional Recurrence
1
Locally Advanced (Inoperable) or Metastatic Breast Cancer
1
HR+/HER2- Breast Cancer
1
HR+ Breast Cancer
1
Interventions
ribociclib
1
palbociclib
1
capivasertib
1
abemaciclib
1
Fulvestrant
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Recruiting
×
Locally Advanced (Inoperable) or Metastatic Breast Cancer
×
Fulvestrant
×
Clear all
NCT04862663
2026-05-27
CAPItello-292
AstraZeneca
Phase 3
Recruiting
895 enrolled